Added value of serum hormone measurements in risk prediction models for breast cancer for women not using exogenous hormones: Results from the EPIC cohort.
<h4>Purpose</h4> <p>Circulating hormone concentrations are associated with breast cancer risk, with well-established associations for postmenopausal women. Biomarkers may represent minimally invasive measures to improve risk prediction models.</p> <h4>Experimental Desi...
Hlavní autoři: | Husing, A, Fortner, R, Kuhn, T, Overvad, K, Tjonneland, A, Olsen, A, Boutron-Ruault, M, Severi, G, Fournier, A, Boeing, H, Trichopoulou, A, Benetou, V, Orfanos, P, Masala, G, Pala, V, Tumino, R, Fasanelli, F, Panico, S, Bueno-de-Mesquita, H, Peeters, P, van Gils, C, Quiros, J, Agudo, A, Sanchez, M, Chirlaque, M, Barricarte, A, Amiano, P, Khaw, K, Travis, R, Dossus, L, Li, K, Ferrari, P, Merritt, M, Tzoulaki, I, Riboli, E, Kaaks, R |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
American Association for Cancer Research
2017
|
Podobné jednotky
-
The half-life of exogenous growth hormone after suppression of endogenous growth hormone secretion with somatostatin.
Autor: Hindmarsh, P, a další
Vydáno: (1989) -
Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study.
Autor: Michaud, D, a další
Vydáno: (2010) -
Treatment of growth-hormone deficiency with growth-hormone-releasing hormone.
Autor: Ross, R, a další
Vydáno: (1987) -
GROWTH HORMONE-RELEASING HORMONE-TREATMENT OF GROWTH-HORMONE DEFICIENT CHILDREN
Autor: Ross, R, a další
Vydáno: (1986) -
Growth hormone-releasing hormone in the diagnosis and treatment of growth hormone deficient children.
Autor: Ross, R, a další
Vydáno: (1986)